Advertisement

HindustanTimes Tue,23 Sep 2014

Ranbaxy shares fall 3.8% after US drug recall

Reuters  Mumbai , March 10, 2014
First Published: 10:20 IST(10/3/2014) | Last Updated: 10:23 IST(10/3/2014)

Shares in Ranbaxy Laboratories Ltd fell as much as 3.8% on Monday after the drug maker recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up was detected.

Advertisement

Ranbaxy confirmed the recall of select batches of the drug, a generic version of Pfizer Inc's Lipitor, but said the company had not received any product complaints.

Shares in Ranbaxy, India's biggest drugmaker by revenue and majority owned by Japan's Daiichi Sankyo Co Ltd, were down 2.9% at 9:20am, underperforming a 0.3% fall in the Nifty.


Advertisement
more from Business

Indian BPOs eye LatAm, West Asia for growth

Expanding into Latin American countries would also help them serve US — their largest client — from closer locations. “West Asia is comparatively a virgin market for the Indian BPM companies.
markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved